FDA Inspection 1214844 — Versiti Indiana, Inc.
The FDA completed an inspection of Versiti Indiana, Inc. on Aug 4, 2023 in Lafayette, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 4, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lafayette, IN (United States)